To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis Interventions:   Biological: CT-P13;   Biological: Remicade Sponsor:   Celltrion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials